Understanding the pathophysiology of hemodialysis access problems as a prelude to developing innovative therapies

被引:0
|
作者
Charles J Diskin
Thomas J Stokes
Linda M Dansby
Lautrec Radcliff
Thomas B Carter
机构
[1] CJ Diskin is a Clinical Associate Professor,
[2] TJ Stokes is a Clinical Associate Professor,undefined
[3] and LM Dansby,undefined
[4] L Radcliff and TB Carter are Nephrologists in the Hypertension,undefined
[5] Nephrology,undefined
[6] Dialysis and Transplantation Clinic,undefined
[7] Auburn University,undefined
[8] Opelika,undefined
[9] AL,undefined
[10] USA.,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Maintenance of a functioning vascular access for hemodialysis is a major challenge. This Review summarizes recent insights into the pathophysiology of the major complications of vascular accesses—thrombosis, stenosis, aneurysms, fistula maturation failure and catheter infection—and outlines innovative ideas for the prevention and treatment of these complications that have emerged as a result of our improved understanding. These ideas include interfering with bacterial quorum sensing, blocking growth factors that are involved in intimal hyperplasia, and inhibiting matrix metalloproteinases.
引用
收藏
页码:628 / 638
页数:10
相关论文
共 50 条
  • [1] Understanding the pathophysiology of hemodialysis access problems as a prelude to developing innovative therapies
    Diskin, Charles J.
    Stokes, Thomas J.
    Dansby, Linda M.
    Radcliff, Lautrec
    Carter, Thomas B.
    NATURE CLINICAL PRACTICE NEPHROLOGY, 2008, 4 (11): : 628 - 638
  • [2] The pathophysiology of brain injury: Understanding innovative drug therapies
    Zafonte, R
    Muizelaar, JP
    Peterson, PI
    JOURNAL OF HEAD TRAUMA REHABILITATION, 1998, 13 (01) : 1 - 10
  • [3] Hemodialysis vascular access dysfunction: From pathophysiology to novel therapies
    Roy-Chaudhury, P
    Kelly, BS
    Zhang, JH
    Narayana, A
    Desai, P
    Melhem, M
    Duncan, H
    Heffelfinger, SC
    BLOOD PURIFICATION, 2003, 21 (01) : 99 - 110
  • [4] Skin aging: Pathophysiology and innovative therapies
    Boismal, Francoise
    Serror, Kevin
    Dobos, Gabor
    Zuelgaray, Elina
    Bensussan, Armand
    Michel, Laurence
    M S-MEDECINE SCIENCES, 2020, 36 (12): : 1163 - 1172
  • [5] Pathophysiology of portal Hypertension as a Condition of innovative Therapies
    Sauerbruch, Tilman
    Trebicka, Jonel
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2010, 60 (11): : 717 - 718
  • [6] Developing innovative targeted therapies for China
    Bahija Jallal
    Journal of Translational Medicine, 10 (Suppl 2)
  • [7] A Patient with Hemodialysis Access Problems
    Niyyar, Vandana Dua
    Lok, Charmaine E.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 13 (09): : 1410 - 1412
  • [8] An innovative approach to temporary hemodialysis vascular access
    Ross, JL
    Staffeld, C
    Lindberg, JS
    Lee, M
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 33 (04) : 718 - 721
  • [9] An innovative approach to temporary hemodialysis vascular access
    Robertshaw H.
    Critical Care, 1 (1):
  • [10] INVISIBLE LEVER FOR ACCESS TO INNOVATIVE THERAPIES IN BULGARIA
    Dobreva, D. P.
    Petrova, T.
    VALUE IN HEALTH, 2016, 19 (07) : A719 - A719